NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

過敏性藥物市場研究報告:按類型(藥物過敏,食品過敏,吸入性過敏),治療(抗過敏藥物,免疫療法),按分銷渠道-2025年預測的COVID-19累積影響

Allergy Drugs Market Research Report by Type, by Treatment, by Distribution Channels, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989548
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
過敏性藥物市場研究報告:按類型(藥物過敏,食品過敏,吸入性過敏),治療(抗過敏藥物,免疫療法),按分銷渠道-2025年預測的COVID-19累積影響 Allergy Drugs Market Research Report by Type, by Treatment, by Distribution Channels, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 185 Pages
簡介

2020年,全球過敏性藥物市場規模為23,486.31百萬美元/20,593,240,000歐元。到2025年底,市場規模預計將達到33,642.94百萬美元/29,489.76百萬歐元。

COVID-19是前所未有的全球公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們解決潛在的COVID-19問題和未來路徑。該報告提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場趨勢以及政府的主要干預措施的變化。

該報告調查了過敏性藥物市場,並提供了市場概況,以及按類型,治療,分銷渠道,地區,COVID-19的累積影響以及進入市場的公司概況的趨勢。

目錄

第1章前言

  • 調查目的
  • 市場細分和範圍
  • 調查對像年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:調查計劃
    • 執行:調查實施
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • Outlook的類型
  • 按產品類型劃分的Outlook
  • 最終用途行業展望
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果
  • 地域增長機會

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章全球過敏藥物市場類型

  • 簡介
  • 藥物過敏
  • 食物過敏
  • 吸入過敏

第7章,按治療方法分類的全球過敏藥物市場

  • 簡介
  • 抗過敏藥
    • 抗組胺藥
    • 皮質類固醇
    • 白三烯抑製劑
  • 免疫療法
    • 舌下免疫療法(SCIT)舌下免疫療法(SLIT)

第8章通過分銷渠道的全球過敏性藥物市場

  • 簡介
  • 醫院藥房
  • 在線藥房
  • 零售藥房和藥店

第9章美洲過敏藥物市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太過敏藥市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章歐洲,中東/非洲過敏性藥物市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第12章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第13章企業可用性概況

  • AbbVie Inc.
  • Aimmune Therapeutics, Inc
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Amneal Pharmaceuticals PLC
  • Astra Biotech GmbH
  • AstraZeneca PLC
  • Aurobindo Pharma
  • Bayer AG
  • Cadila Healthcare Limited
  • Chongqing Huapont Pharmaceutical Co., Ltd
  • Cipla Inc
  • Dr. Reddy's Laboratories Ltd
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • HAL Allergy B.V.
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services, Inc
  • LETI Pharma GmBH
  • Lupin Limited
  • Magna Pharmaceuticals, Inc.
  • Merck & Co., Inc
  • Mylan N.V
  • Novartis AG
  • Sanofi SA
  • Stallergenes Greer Ltd
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd

第14章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-434CCDA051E6

The Global Allergy Drugs Market size was estimated at USD 23.48 Billion in 2020 and expected to reach USD 25.35 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.29% to reach USD 37.87 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Allergy Drugs Market was studied across Drug Allergy, Food Allergy, and Inhaled Allergy.

Based on Treatment, the Allergy Drugs Market was studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs is further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy is further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).

Based on Distribution Channels, the Allergy Drugs Market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.

Based on Geography, the Allergy Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market, including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abello A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy's Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Allergy Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Allergy Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Allergy Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Treatment Outlook
  • 3.5. Distribution Channels Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of allergy globally
      • 5.1.1.2. Increasing development of allergy-specific drugs
      • 5.1.1.3. Changing lifestyle with increasing tobacco consumption
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over patent expiration and extensive competition from generic drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of immunotherapy and development of increasing ways of administration
      • 5.1.3.2. Rising consumer awareness on food allergies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs for allergy
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Allergy Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Drug Allergy
  • 6.3. Food Allergy
  • 6.4. Inhaled Allergy

7. Allergy Drugs Market, by Treatment

  • 7.1. Introduction
  • 7.2. Anti-allergy Drugs
    • 7.2.1. Antihistamines
    • 7.2.2. Corticosteroids
    • 7.2.3. Leukotriene Inhibitors
  • 7.3. Immunotherapy
    • 7.3.1. Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT)

8. Allergy Drugs Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies & Drug Stores

9. Americas Allergy Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Allergy Drugs Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Allergy Drugs Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AbbVie Inc.
  • 13.2. Aimmune Therapeutics, Inc
  • 13.3. ALK-Abello A/S
  • 13.4. Allergy Therapeutics
  • 13.5. Amneal Pharmaceuticals PLC
  • 13.6. Astra Biotech GmbH
  • 13.7. AstraZeneca PLC
  • 13.8. Aurobindo Pharma
  • 13.9. Bayer AG
  • 13.10. Cadila Healthcare Limited
  • 13.11. Chongqing Huapont Pharmaceutical Co., Ltd
  • 13.12. Cipla Inc
  • 13.13. Dr. Reddy's Laboratories Ltd
  • 13.14. F. Hoffmann-La Roche AG
  • 13.15. GlaxoSmithKline PLC
  • 13.16. HAL Allergy B.V.
  • 13.17. Hikma Pharmaceuticals PLC
  • 13.18. Johnson & Johnson Services, Inc
  • 13.19. LETI Pharma GmBH
  • 13.20. Lupin Limited
  • 13.21. Magna Pharmaceuticals, Inc.
  • 13.22. Merck & Co., Inc
  • 13.23. Mylan N.V
  • 13.24. Novartis AG
  • 13.25. Sanofi SA
  • 13.26. Stallergenes Greer Ltd
  • 13.27. Sun Pharmaceutical Industries Ltd
  • 13.28. Teva Pharmaceutical Industries Ltd

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALLERGY DRUGS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL ALLERGY DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL ALLERGY DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2026
  • FIGURE 20. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, 2018-2026 (USD BILLION)
  • FIGURE 27. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2026 (%)
  • FIGURE 33. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2026
  • FIGURE 35. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 42. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 44. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. BRAZIL ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. CANADA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. MEXICO ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. CALIFORNIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. FLORIDA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. ILLINOIS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. NEW YORK ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. OHIO ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. PENNSYLVANIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. TEXAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 57. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 59. CHINA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. INDIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. INDONESIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. JAPAN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. THAILAND ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 68. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 70. FRANCE ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. GERMANY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. ITALY ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. QATAR ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. RUSSIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 76. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 77. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 78. SPAIN ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. GLOBAL ALLERGY DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 82. GLOBAL ALLERGY DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 83. GLOBAL ALLERGY DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 84. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ALLERGY DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ALLERGY DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DRUG ALLERGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ALLERGY DRUGS MARKET SIZE, BY FOOD ALLERGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ALLERGY DRUGS MARKET SIZE, BY INHALED ALLERGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTI-ALLERGY DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ALLERGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ALLERGY DRUGS MARKET SIZE, BY LEUKOTRIENE INHIBITORS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ALLERGY DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL ALLERGY DRUGS MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY (SCIT) SUBLINGUAL IMMUNOTHERAPY (SLIT), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL ALLERGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL ALLERGY DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL ALLERGY DRUGS MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. AMERICAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. AMERICAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. ARGENTINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. BRAZIL ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. BRAZIL ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. CANADA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. CANADA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. CANADA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. MEXICO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. MEXICO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. MEXICO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. UNITED STATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. CALIFORNIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. CALIFORNIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. CALIFORNIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. FLORIDA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. FLORIDA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. FLORIDA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ILLINOIS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. ILLINOIS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ILLINOIS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. NEW YORK ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. NEW YORK ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. NEW YORK ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. OHIO ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. OHIO ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. OHIO ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. PENNSYLVANIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. PENNSYLVANIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. PENNSYLVANIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. TEXAS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. TEXAS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. TEXAS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. ASIA-PACIFIC ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. CHINA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. CHINA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. CHINA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. INDIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. INDIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. INDIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. INDONESIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. INDONESIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. JAPAN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. JAPAN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. JAPAN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. MALAYSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. PHILIPPINES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SOUTH KOREA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. THAILAND ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. THAILAND ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. THAILAND ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. FRANCE ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. FRANCE ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. FRANCE ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. GERMANY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. GERMANY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. GERMANY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. ITALY ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. ITALY ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. ITALY ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. NETHERLANDS ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. QATAR ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. QATAR ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. QATAR ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. RUSSIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. RUSSIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. SAUDI ARABIA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SOUTH AFRICA ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. SPAIN ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. SPAIN ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. SPAIN ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. UNITED ARAB EMIRATES ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY TREATMENT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. UNITED KINGDOM ALLERGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. GLOBAL ALLERGY DRUGS MARKET: SCORES
  • TABLE 125. GLOBAL ALLERGY DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 126. GLOBAL ALLERGY DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 127. GLOBAL ALLERGY DRUGS MARKET: RANKING
  • TABLE 128. GLOBAL ALLERGY DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 129. GLOBAL ALLERGY DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 130. GLOBAL ALLERGY DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 131. GLOBAL ALLERGY DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 132. GLOBAL ALLERGY DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 133. GLOBAL ALLERGY DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 134. GLOBAL ALLERGY DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 135. GLOBAL ALLERGY DRUGS MARKET: LICENSE & PRICING
  • TABLE 136. GLOBAL ALLERGY DRUGS MARKET: CONTACT DETAILS